JANA Partners Management LP Has $256.90 Million Stock Position in The Cooper Companies, Inc. $COO

Posted by Francis Steltz on Sep 4th, 2026

JANA Partners Management LP increased its stake in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 0.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,582,480 shares of the medical device company’s stock after acquiring an additional 17,322 shares during the period. Cooper Companies makes up approximately 13.5% of JANA Partners Management LP’s investment portfolio, making the stock its 2nd biggest position. JANA Partners Management LP’s holdings in Cooper Companies were worth $256,900,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. Avalon Trust Co bought a new stake in shares of Cooper Companies in the 2nd quarter valued at approximately $25,000. Root Financial Partners LLC increased its position in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 162 shares during the last quarter. SJS Investment Consulting Inc. increased its position in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares during the last quarter. Elevation Wealth Partners LLC raised its holdings in Cooper Companies by 1,136.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after buying an additional 375 shares during the period. Finally, Continuum Advisory LLC purchased a new stake in Cooper Companies during the 2nd quarter valued at $30,000. 24.39% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a research note on Wednesday, May 27th. BNP Paribas Exane reduced their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research note on Monday, June 8th. UBS Group assumed coverage on shares of Cooper Companies in a report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 target price for the company. JPMorgan Chase & Co. dropped their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Finally, Robert W. Baird cut their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $81.64.

Check Out Our Latest Analysis on Cooper Companies

Cooper Companies Price Performance

COO opened at $70.64 on Friday. The business has a fifty day moving average of $72.74 and a 200 day moving average of $70.46. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The stock has a market cap of $13.78 billion, a P/E ratio of 59.86, a PEG ratio of 1.82 and a beta of 0.82.

Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the company posted $0.96 EPS. Cooper Companies’s quarterly revenue was up 7.9% on a year-over-year basis. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Profile

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.